{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1116.58",
  "meta": {
    "versionId": "3",
    "lastUpdated": "2015-07-14T01:00:00.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.58",
  "version": "20150714",
  "name": "Trastuzumab Administration",
  "status": "active",
  "date": "2015-07-14T01:00:00-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "compose": {
    "include": [
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20220301",
        "concept": [
          {
            "code": "327397006",
            "display": "Trastuzumab (product)"
          },
          {
            "code": "327399009",
            "display": "Trastuzumab 150mg powder for infusion solution vial (product)"
          },
          {
            "code": "375356000",
            "display": "Trastuzumab 440mg powder for injection solution vial (product)"
          },
          {
            "code": "387003001",
            "display": "Trastuzumab (substance)"
          },
          {
            "code": "702836004",
            "display": "Trastuzumab emtansine (substance)"
          }
        ]
      }
    ]
  }
}